Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04482309 |
|---|---|
| Brief Title: | A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors (DPT02) |
| First Submitted : | July 20, 2020 |
| First Submitted that Met QC Criteria : | July 20, 2020 |
| First Posted : | July 22, 2020 |
| Last Update Submitted that Met QC Criteria : | February 5, 2024 |
| Last Update Posted : | February 6, 2024 |